Free Trial

Addex Therapeutics (ADXN) Short Interest Ratio & Short Volume

Addex Therapeutics logo
$7.60 +0.22 (+2.98%)
(As of 01:45 PM ET)

Addex Therapeutics Short Interest Data

Addex Therapeutics (ADXN) has a short interest of 3,500 shares, representing 0.43% of the float (the number of shares available for trading by the public). This marks a -64.65% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 97,964 shares to cover all short positions.

Current Short Interest
3,500 shares
Previous Short Interest
9,900 shares
Change Vs. Previous Month
-64.65%
Dollar Volume Sold Short
$34,125.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
1,060,000 shares
Float Size
818,900 shares
Short Percent of Float
0.43%
Today's Trading Volume
3,830 shares
Average Trading Volume
97,964 shares
Today's Volume Vs. Average
4%
Short Selling Addex Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ADXN Short Interest Over Time

ADXN Days to Cover Over Time

ADXN Percentage of Float Shorted Over Time

Addex Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20243,500 shares $34,125.00 -64.7%0.4%0 $9.75
10/15/20249,900 shares $103,455.00 +3.1%1.2%0 $10.45
9/30/20249,600 shares $93,792.00 -62.2%1.2%0 $9.77
9/15/202425,400 shares $244,856.00 -74.0%3.1%0.1 $9.64
8/31/202497,500 shares $1.06 million +9,650.0%11.9%0.4 $10.86
8/15/20241,000 shares $7,800.00 -23.1%0.1%0.3 $7.80
7/31/20241,300 shares $10,855.00 -23.5%0.2%0.4 $8.35
7/15/20241,700 shares $14,144.00 -39.3%0.2%0.2 $8.32
6/30/20242,800 shares $23,016.56 -40.4%0.3%0.2 $8.22
6/15/20244,700 shares $40,467.00 -27.7%0.6%0.3 $8.61
5/31/20246,500 shares $55,900.00 +18.2%0.8%0.3 $8.60
5/15/20245,500 shares $49,500.00 -62.6%0.7%0.3 $9.00
4/30/202414,700 shares $112,455.00 -32.3%1.9%0.8 $7.65
4/15/202421,700 shares $537,075.00 +149.4%2.7%1.3 $24.75
3/31/20248,700 shares $111,360.00 -26.9%0.9%0.5 $12.80
3/15/202411,900 shares $139,349.00 +41.7%1.2%1.2 $11.71
2/29/20248,400 shares $79,884.00 +33.3%0.8%0.9 $9.51
2/15/20246,300 shares $66,087.00 -27.6%0.6%0.7 $10.49
1/31/20248,700 shares $94,308.00 +222.2%0.9%0.8 $10.84
1/15/20242,700 shares $18,765.00 +12.5%0.3%0.3 $6.95
12/31/20232,400 shares $14,520.00 -33.3%0.2%0.2 $6.05
12/15/20233,600 shares $19,548.00 -14.3%0.4%0.4 $5.43
11/30/20234,200 shares $23,310.00 -25.0%0.5%0.5 $5.55
11/15/20235,600 shares $34,160.00 +5.7%0.8%0.8 $6.10
10/31/20235,300 shares $33,337.00 No Change0.8%1 $6.29
10/15/20235,300 shares $43,036.00 -95.4%N/A1.3 $8.12
9/30/2023115,900 shares $44,540.37 -35.0%N/A1.7 $0.38
9/15/2023178,200 shares $74,844.00 +76.1%N/A3.3 $0.42
8/31/2023101,200 shares $46,248.40 -8.9%N/A2 $0.46
8/15/2023111,100 shares $59,216.30 -4.4%N/A1.7 $0.53
7/31/2023116,200 shares $65,072.00 -16.6%N/A0.3 $0.56
7/15/2023139,400 shares $82,106.60 -13.6%N/A0.4 $0.59
6/30/2023161,300 shares $84,037.30 -28.7%N/A0.4 $0.52
6/15/2023226,300 shares $149,358.00 -40.4%3.0%0.5 $0.66
5/31/2023379,900 shares $246,593.09 -43.6%5.1%0.7 $0.65
5/15/2023673,100 shares $567,086.75 +358.5%9.0%1.2 $0.84
4/30/2023146,800 shares $104,183.96 -34.2%N/A0.4 $0.71
4/15/2023223,100 shares $172,980.59 +195.9%N/A0.5 $0.78
3/31/202375,400 shares $71,343.48 -7.6%N/A0.2 $0.95
3/15/202381,600 shares $89,760.00 -75.9%N/A0.3 $1.10
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
2/28/2023338,700 shares $694,335.00 +149.8%N/A1.1 $2.05
2/15/2023135,600 shares $203,400.00 -55.2%N/A0.5 $1.50
1/31/2023302,400 shares $323,568.00 +484.9%N/A1.3 $1.07
1/15/202351,700 shares $44,979.00 +28.0%N/A0.3 $0.87
12/30/202240,400 shares $25,456.08 +15.8%0.5%0.3 $0.63
12/15/202234,900 shares $21,149.40 -25.3%0.9%0.3 $0.61
11/30/202246,700 shares $35,954.33 -57.4%1.6%0.3 $0.77
11/15/2022109,700 shares $89,416.47 +247.2%3.6%0.7 $0.82
10/31/202231,600 shares $26,860.00 -41.6%0.6%0.2 $0.85
10/15/202254,100 shares $43,280.00 -43.1%0.9%0.2 $0.80
9/30/202295,100 shares $76,060.98 +37.0%1.7%0 $0.80
9/15/202269,400 shares $66,624.00 -46.7%1.2%0 $0.96
8/31/2022130,300 shares $140,724.00 -11.2%2.3%0 $1.08
8/15/2022146,800 shares $204,052.00 -30.0%2.6%0.1 $1.39
7/31/2022209,800 shares $242,885.46 +11,555.6%3.4%0.1 $1.16
7/15/20221,800 shares $1,781.46 -71.9%0.0%0 $0.99
6/30/20226,400 shares $7,360.00 +106.5%0.1%0.2 $1.15
6/15/20223,100 shares $10,571.00 +29.2%0.1%0.1 $3.41
5/31/20222,400 shares $9,048.00 +2,300.0%0.0%0.5 $3.77
5/15/2022100 shares $417.00 -80.0%N/A0 $4.17
4/30/2022500 shares $2,590.00 +25.0%N/A0.2 $5.18
4/15/2022400 shares $1,754.76 +300.0%N/A0.1 $4.39
3/31/2022100 shares $508.00 -50.0%N/A0 $5.08
3/15/2022200 shares $908.00 No ChangeN/A0.1 $4.54
2/28/2022200 shares $1,062.00 No ChangeN/A0 $5.31
2/15/2022200 shares $1,139.80 -93.3%N/A0 $5.70
1/31/20223,000 shares $17,190.00 +500.0%0.1%0.7 $5.73
1/15/2022500 shares $2,985.00 -96.4%0.0%0.1 $5.97
12/31/202113,800 shares $86,802.00 +885.7%0.3%4.3 $6.29
12/15/20211,400 shares $9,114.00 -12.5%0.0%0.5 $6.51
11/30/20211,600 shares $11,216.00 +6.7%0.0%0.8 $7.01
11/15/20211,500 shares $12,060.00 +87.5%0.0%0.8 $8.04
10/29/2021800 shares $6,312.00 -11.1%0.0%0.4 $7.89
10/15/2021900 shares $7,659.00 -25.0%0.0%0.4 $8.51
9/30/20211,200 shares $10,812.00 -63.6%0.0%0.3 $9.01
9/15/20213,300 shares $32,043.00 -13.2%0.1%0.8 $9.71
8/31/20213,800 shares $36,974.00 +111.1%0.1%0.8 $9.73
8/13/20211,800 shares $17,874.00 +157.1%0.0%0.4 $9.93
7/30/2021700 shares $6,895.00 -69.6%0.0%0.1 $9.85
7/15/20212,300 shares $22,195.00 +1,050.0%N/A0.4 $9.65
6/30/2021200 shares $1,912.00 -96.0%N/A0 $9.56
6/15/20215,000 shares $55,000.00 +354.6%N/A0.7 $11.00
5/28/20211,100 shares $10,285.11 -73.2%N/A0.2 $9.35
5/14/20214,100 shares $37,064.00 -43.1%N/A0.4 $9.04
4/30/20217,200 shares $71,928.00 +200.0%N/A0.4 $9.99
4/15/20212,400 shares $25,128.00 +140.0%N/A0.1 $10.47
3/31/20211,000 shares $10,400.00 -47.4%N/A0 $10.40
3/15/20211,900 shares $20,501.00 -71.2%N/A0 $10.79
2/26/20216,600 shares $74,580.00 +57.1%N/A0.1 $11.30
2/12/20214,200 shares $47,880.00 -67.9%N/A0 $11.40
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
1/29/202113,100 shares $144,755.00 +1,090.9%N/A0.1 $11.05
1/15/20211,100 shares $11,814.00 No ChangeN/A0 $10.74

ADXN Short Interest - Frequently Asked Questions

What is Addex Therapeutics' current short interest?

Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 3,500 shares of ADXN short. 0.43% of Addex Therapeutics' shares are currently sold short. Learn More on Addex Therapeutics' current short interest.

What is a good short interest percentage for Addex Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.43% of Addex Therapeutics' floating shares are currently sold short.

Is Addex Therapeutics' short interest increasing or decreasing?

Addex Therapeutics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 3,500 shares, a decline of 64.6% from the previous total of 9,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Addex Therapeutics' float size?

Addex Therapeutics currently has issued a total of 1,060,000 shares. Some of Addex Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Addex Therapeutics currently has a public float of 818,900 shares.

How does Addex Therapeutics' short interest compare to its competitors?

0.43% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Addex Therapeutics: Estrella Immunopharma, Inc. (0.06%), Acasti Pharma Inc. (2.47%), Janone Inc. (1.13%), Lantern Pharma Inc. (2.06%), Citius Pharmaceuticals, Inc. (6.52%), Surrozen, Inc. (1.47%), BioVie Inc. (35.04%), KALA BIO, Inc. (1.02%), HCW Biologics Inc. (0.04%), RenovoRx, Inc. (0.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Addex Therapeutics stock?

Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. ADXN shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Addex Therapeutics?

A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further.

How often is Addex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ADXN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners